Ilan Daskal Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ilan Daskal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ilan Daskal. Ilan Daskal is EVP, CFO in BIO-RAD LABORATORIES, INC. ($BIO) and EVP, Chief Financial Officer in BIO-RAD LABORATORIES, INC. ($BIO) and Executive Vice President & CFO in INTERNATIONAL RECTIFIER CORP /DE/ ($IRF) and EVP & CFO Designee in SUNEDISON, INC. ($SUNE) and EVP, Chief Financial Officer in CEPHEID ($CPHD) and Director in IXIA ($XXIA) and Director in NATUS MEDICAL INC ($BABY).
Latest Insider Trading Transactions of Ilan Daskal
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIO, CPHD, IRF, XXIA, BABY, SUNE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | BABY | NATUS MEDICAL INC | Daskal Ilan | Director | Grant | A | 28.77 | 5,214 | 150,007 | 13,862 | 8.6 K to 13.9 K (+60.29 %) |
Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 700 | 0 | 2,100 | |
Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Payment of Exercise | F | 592.23 | 250 | 148,058 | 907 | 1.2 K to 907 (-21.61 %) |
Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Buy | M | 0.00 | 700 | 0 | 1,157 | 457 to 1.2 K (+153.17 %) |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | A | 524.30 | 2,166 | 1,135,634 | 2,166 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 2,166 | 0 | 2,166 | |
Jun 22 2020 | BABY | NATUS MEDICAL INC | Daskal Ilan | Director | Grant | A | 21.07 | 3,560 | 75,009 | 11,148 | 7.6 K to 11.1 K (+46.92 %) |
Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 700 | 0 | 2,800 | |
Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Payment of Exercise | F | 403.06 | 243 | 97,944 | 457 | 700 to 457 (-34.71 %) |
Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Buy | M | 0.00 | 700 | 0 | 700 | 0 to 700 |
Mar 20 2020 | BABY | NATUS MEDICAL INC | Daskal Ilan | Director | Grant | A | 19.77 | 7,588 | 150,015 | 7,588 | 0 to 7.6 K |
Apr 09 2019 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, CFO | Option Exercise | A | 309.84 | 3,500 | 1,084,440 | 3,500 | |
Apr 09 2019 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, CFO | Option Exercise | A | 0.00 | 3,500 | 0 | 3,500 | |
Apr 20 2017 | XXIA | IXIA | Daskal Ilan | Director | Option Exercise | D | 10.30 | 15,000 | 154,500 | 0 | |
Apr 20 2017 | XXIA | IXIA | Daskal Ilan | Director | Option Exercise | D | 15.55 | 15,000 | 233,250 | 0 | |
Apr 20 2017 | XXIA | IXIA | Daskal Ilan | Director | Sell | D | 19.65 | 16,140 | 317,151 | 0 | 16.1 K to 0 (-100.00 %) |
Jun 07 2016 | XXIA | IXIA | Daskal Ilan | Director | Option Exercise | A | 10.30 | 15,000 | 154,500 | 15,000 | |
Jun 07 2016 | XXIA | IXIA | Daskal Ilan | Director | Grant | A | 0.00 | 9,709 | 0 | 16,140 | 6.4 K to 16.1 K (+150.97 %) |
Apr 11 2016 | SUNE | SUNEDISON, INC. | Daskal Ilan | EVP & CFO Designee | Grant | A | 0.36 | 400,000 | 144,000 | 400,000 | 0 to 400 K |
Aug 11 2015 | XXIA | IXIA | Daskal Ilan | Director | Option Exercise | A | 15.55 | 15,000 | 233,250 | 15,000 | |
Aug 11 2015 | XXIA | IXIA | Daskal Ilan | Director | Grant | A | 0.00 | 6,431 | 0 | 6,431 | 0 to 6.4 K |
Apr 13 2015 | CPHD | CEPHEID | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | A | 56.01 | 100,000 | 5,601,000 | 100,000 | |
Apr 13 2015 | CPHD | CEPHEID | Daskal Ilan | EVP, Chief Financia ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 26 2012 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | M | 0.00 | 3,334 | 0 | 6,666 | |
Jun 26 2012 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Payment of Exercise | F | 19.94 | 1,222 | 24,367 | 17,942 | 19.2 K to 17.9 K (-6.38 %) |
Jun 26 2012 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Grant | A | 0.00 | 3,334 | 0 | 19,164 | 15.8 K to 19.2 K (+21.06 %) |
May 21 2012 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Buy | P | 17.80 | 3,000 | 53,400 | 15,830 | 12.8 K to 15.8 K (+23.38 %) |
May 15 2012 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | M | 0.00 | 1,666 | 0 | 0 | |
May 15 2012 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Payment of Exercise | F | 19.49 | 611 | 11,908 | 12,830 | 13.4 K to 12.8 K (-4.55 %) |
May 15 2012 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Grant | A | 0.00 | 1,666 | 0 | 13,441 | 11.8 K to 13.4 K (+14.15 %) |
Jul 08 2011 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | M | 0.00 | 4,000 | 0 | 8,000 | |
Jul 08 2011 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Payment of Exercise | F | 28.60 | 1,867 | 53,396 | 3,022 | 4.9 K to 3 K (-38.19 %) |
Jul 08 2011 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Grant | A | 0.00 | 4,000 | 0 | 4,889 | 889 to 4.9 K (+449.94 %) |
May 13 2011 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | M | 0.00 | 1,667 | 0 | 1,666 | |
May 13 2011 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Payment of Exercise | F | 31.20 | 778 | 24,274 | 889 | 1.7 K to 889 (-46.67 %) |
May 13 2011 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Grant | A | 0.00 | 1,667 | 0 | 1,667 | 0 to 1.7 K |
May 14 2010 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | M | 0.00 | 1,667 | 0 | 3,333 | |
May 14 2010 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Sell | D | 22.03 | 611 | 13,460 | 6,411 | 7 K to 6.4 K (-8.70 %) |
May 14 2010 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Grant | A | 0.00 | 1,667 | 0 | 7,022 | 5.4 K to 7 K (+31.13 %) |
Oct 06 2009 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | M | 0.00 | 8,334 | 0 | 16,666 | |
Oct 06 2009 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Sell | D | 20.03 | 2,979 | 59,669 | 5,355 | 8.3 K to 5.4 K (-35.75 %) |
Oct 06 2009 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Grant | A | 0.00 | 8,334 | 0 | 8,334 | 0 to 8.3 K |
May 14 2009 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
May 14 2009 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | A | 12.95 | 25,000 | 323,750 | 25,000 | |
Nov 12 2008 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Nov 12 2008 | IRF | INTERNATIONAL RECT ... | Daskal Ilan | Executive Vice Pres ... | Option Exercise | A | 12.07 | 75,000 | 905,250 | 75,000 |
Page: 1